Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

ZILRETTA in Subjects With Shoulder Osteoarthritis

ClinicalTrials.gov ID: NCT06269705

Public ClinicalTrials.gov record NCT06269705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 6:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral Osteoarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo Secondary Objective: * To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with glenohumeral OA relative to triamcinolone acetonide injectable suspension, and normal saline placebo * To assess the safety of ZILRETTA in subjects with glenohumeral OA relative to normal saline placebo

Study identification

NCT ID
NCT06269705
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 4, 2024
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
May 28, 2026

2024 – 2026

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Alabama Orthopaedic Center- Research Vestavia Hills Alabama 35243
Onyx Clinical Research Surprise Arizona 85374
Tucson Orthopaedic Institute (TOI) - East Office Tucson Arizona 85712
Horizon Clinical Research La Mesa California 91942
Napa Pain Institute Napa California 94558
Stanford University - Sports Medicine Clinic Redwood City California 94063
International Spine, Pain & Performance Center Washington D.C. District of Columbia 20006
Orthopedic Center of Palm Beach City Atlantis Florida 33462
Baptist Health Orthopedic Care - Miami Gardens Maimi Florida 33056
Infinite Clinical Research Miami Florida 33133
Gulfcoast Research Institute Sarasota Florida 34232-6028
Clinical Research of West Florida Tampa Florida 33606
Hospital for Special Services West Palm Beach Florida 33401
Injury Care Research Boise Idaho 83713
Kansas City Bone & Joint Clinic - Overland Park Overland Park Kansas 66211
Ochsner Sports Medicine Institute New Orleans Louisiana 70121
New England Baptist Hospital Boston Massachusetts 02120-2847
Oakland Medical Center Troy Michigan 48085-5524
Sundance Clinical Research St Louis Missouri 63141
New York-Presbyterian Queens Flushing New York 11355-5045
West Clinical Research Morehead City North Carolina 28557
University of Cincinnati Cincinnati Ohio 45267-0212
Ohio State University Columbus Ohio 43210
University Orthopedics Center Altoona Pennsylvania 16602
Altoona Arthritis & Osteoporosis Center - Altoona Center for Clinical Research Duncansville Pennsylvania 16653
University Orthopedics Center (UOC) - State College State College Pennsylvania 16801
Medical University Health - West Ashley Medical Pavilion Charleston South Carolina 29407
Texas Orthopedic Specialists, PLLC Bedford Texas 76021
First Surgical Hospital Bellaire Texas 77401
El Paso Clinical Trials, LLC El Paso Texas 79935-3013
Physicians Research Options Draper Utah 84020
Spectrum Medical Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06269705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2026 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06269705 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →